Literature DB >> 34718938

The role of microRNAs in diseases and related signaling pathways.

Atena Vaghf1, Behzad Khansarinejad2, Ehsanollah Ghaznavi-Rad3, Mahdieh Mondanizadeh4.   

Abstract

MicroRNAs (miRNAs) are epigenetic regulators of the gene expression and act through posttranslational modification. They bind to 3'-UTR of target mRNAs to inhibit translation or increase the degradation mRNA in many tissues. Any alteration in the level of miRNA expression in many human diseases indicates their involvement in the pathogenesis of many diseases. On the other hand, the regulation of the signaling pathways is necessary for the maintenance of natural and physiological characteristics of any cell. It is worth mentioning that dysfunction of the signaling pathways manifests itself as a disorder or disease. The significant evidence report that miRNAs regulate the several signaling pathways in many diseases. Base on previous studies, miRNAs can be used for therapeutic or diagnostic purposes. According to the important role of miRNAs on the cell signaling pathways, this article reviews miRNAs involvement in incidence of diseases by changing signaling pathways.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Human diseases; MicroRNA; Pathogenesis mechanisms; Signaling pathways; mRNA

Mesh:

Substances:

Year:  2021        PMID: 34718938     DOI: 10.1007/s11033-021-06725-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  135 in total

Review 1.  Biogenesis of small RNAs in animals.

Authors:  V Narry Kim; Jinju Han; Mikiko C Siomi
Journal:  Nat Rev Mol Cell Biol       Date:  2009-02       Impact factor: 94.444

Review 2.  Analytical aspects of microRNA in diagnostics: a review.

Authors:  Mariàngels de Planell-Saguer; María Celina Rodicio
Journal:  Anal Chim Acta       Date:  2011-05-20       Impact factor: 6.558

3.  MicroRNA-124 regulates neuronal differentiation of mesenchymal stem cells by targeting Sp1 mRNA.

Authors:  Mahdieh Mondanizadeh; Ehsan Arefian; Ghasem Mosayebi; Massoud Saidijam; Behzad Khansarinejad; Seyed Mahmoud Hashemi
Journal:  J Cell Biochem       Date:  2015-06       Impact factor: 4.429

4.  Two Triacylglycerol Pathway Genes, CTDNEP1 and LPIN1, are Down-Regulated by hsa-miR-122-5p in Hepatocytes.

Authors:  Mahmood Naderi; Abdolreza Pazouki; Ehsan Arefian; Seyed Mahmoud Hashemi; Fatemeh Jamshidi-Adegani; Omid Gholamalamdari; Sara Soudi; Kayhan Azadmanesh; Siamak Mirab Samiee; Shahin Merat; Mohammad Gholami Fesharaki; Mahdieh Mondanizadeh; Mohammad Vasei; Masoud Soleimani
Journal:  Arch Iran Med       Date:  2017-03       Impact factor: 1.354

Review 5.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

Authors:  Rajesha Rupaimoole; Frank J Slack
Journal:  Nat Rev Drug Discov       Date:  2017-02-17       Impact factor: 84.694

Review 6.  MicroRNA.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-10-23       Impact factor: 10.793

Review 7.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

8.  Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastriczzm321990Cancer in Human

Authors:  Pegah Parvaee; Hossein Sarmadian; Behzad Khansarinejad; Mahmood Amini; Mahdieh Mondanizadeh
Journal:  Asian Pac J Cancer Prev       Date:  2019-05-25

Review 9.  The Implications of ncRNAs in the Development of Human Diseases.

Authors:  Elena López-Jiménez; Eduardo Andrés-León
Journal:  Noncoding RNA       Date:  2021-02-24

10.  Alterations in The Plasma Expression of mir-15b, mir-195 and the Tumor-Suppressor Gene DLEU7 in Patients with B-Cell Chronic Lymphocytic Leukemia.

Authors:  Malihe Bagheri; Behzad Khansarinejad; Ghasem Mosayebi; Alireza Moradabadi; Mahdieh Mondanizadeh
Journal:  Rep Biochem Mol Biol       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.